Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.80
-0.23 (-2.86%)
At close: Jun 13, 2025, 3:59 PM
7.89
1.09%
After-hours: Jun 13, 2025, 04:57 PM EDT
-2.86% (1D)
| Bid | 7.6 |
| Market Cap | 47.73M |
| Revenue (ttm) | 3.27M |
| Net Income (ttm) | -53.26M |
| EPS (ttm) | -17.47 |
| PE Ratio (ttm) | -0.45 |
| Forward PE | -0.89 |
| Analyst | Buy |
| Ask | 8.36 |
| Volume | 133,939 |
| Avg. Volume (20D) | 159,288 |
| Open | 7.69 |
| Previous Close | 8.03 |
| Day's Range | 7.59 - 8.31 |
| 52-Week Range | 3.76 - 46.80 |
| Beta | 2.69 |
About ALGS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALGS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-19.55%
Aligos Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
4 months ago
-19.25%
Aligos Therapeutics shares are trading lower after the company announced a $105 million private placement financing round.
